rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Scott Hutton

President & CEO

Company insider

Files Form 4 as: President & CEO, Biodesix; General Manager, VI, Spectranetics.

Every Form 4 they filed

In numbers

Trades disclosed
114
Buys
2
Sells
26
Bought
$118K
Sold
$487K
Companies
2
Companies where not an officer
0
First trade
31 Jan 2017
Last trade
23 Feb 2026
Last filed
23 Feb 2026

Companies traded

Where they are an officer
BDSX BiodesixDirector, Officer · Diagnostics & Labs · last 23 Feb 20262 buys · 26 sells
SpectraneticsOfficer · last 9 Aug 20170 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Feb 2026filed 23 Feb 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Sold$19K1,490 at $12.78filing
23 Feb 2026filed 23 Feb 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Sold$19K1,490 at $12.78filing
20 Feb 2026filed 23 Feb 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—4,844filing
20 Feb 2026filed 23 Feb 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—4,844 at $0.00filing
20 Feb 2026filed 23 Feb 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—4,844 at $0.00filing
20 Feb 2026filed 23 Feb 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—4,844filing
10 Feb 2026filed 11 Feb 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Sold$36K3,559 at $10.08filing
10 Feb 2026filed 11 Feb 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Sold$36K3,559 at $10.08filing
9 Feb 2026filed 11 Feb 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—9,998filing
9 Feb 2026filed 11 Feb 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—610 at $0.00filing
9 Feb 2026filed 11 Feb 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—610 at $0.00filing
9 Feb 2026filed 11 Feb 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—9,388 at $0.00filing
9 Feb 2026filed 11 Feb 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—9,388 at $0.00filing
9 Feb 2026filed 11 Feb 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—9,998filing
16 Jan 2026filed 20 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Sold$7,905970 at $8.15filing
16 Jan 2026filed 20 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Sold$7,906970 at $8.15filing
15 Jan 2026filed 20 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—2,633filing
15 Jan 2026filed 20 Jan 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,633 at $0.00filing
15 Jan 2026filed 20 Jan 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,633 at $0.00filing
15 Jan 2026filed 20 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—2,633filing

Sectors

Health Care28

Buys in green, sells in red, by the company’s sector.

Related people

John PatienceDirector and Other role · Director and Other at Biodesix, filing Form 4 there in the last year
Jack W. Schuler10% owner and Other role · 10% owner and Other at Biodesix, filing Form 4 there in the last year
Chris VazquezChief Accounting Officer · Chief Accounting Officer at Biodesix, filing Form 4 there in the last year
Robin Harper CowieCFO, Sec'y & Treasurer · CFO, Sec'y & Treasurer at Biodesix, filing Form 4 there in the last year
Gary Anthony PestanoChief Development Officer · Chief Development Officer at Biodesix, filing Form 4 there in the last year